Provided by Tiger Trade Technology Pte. Ltd.

SIMCERE PHARMA

10.990
-0.110-0.99%
Volume:4.36M
Turnover:47.93M
Market Cap:28.22B
PE:17.45
High:11.100
Open:11.180
Low:10.960
Close:11.100
52wk High:14.247
52wk Low:9.070
Shares:2.57B
HK Float Shares:2.57B
Volume Ratio:0.75
T/O Rate:0.17%
Dividend:0.21
Dividend Rate:1.91%
EPS(LYR):0.630
ROE:18.77%
ROA:7.78%
PB:2.57
PE(LYR):17.45
PS:2.77

Loading ...

Simcere Sanbexin Added to China 2026 National Essential Medicines List

Reuters
·
Jul 09

Simcere Pharmaceutical - Sanbexin Included in 2026 National Essential Medicines List

THOMSON REUTERS
·
Jul 09

Simcere Pharma Cancels 27.50 Million Repurchased Shares, Cutting Share Base by 1.06%

Bulletin Express
·
Jul 06

Hong Kong Innovative Drug Stocks Jump With HAIXI PHARMA and INNOCARE up 7%; KEYMED up 5%, REMEGEN up 4%

Tiger Newspress
·
Jul 06

SIMCERE PHARMA Shares Surge in Morning Trading Following Research Agreement and Bullish Analyst Target

Deep News
·
Jul 02

SIMCERE PHARMA Shares Surge Again, Nearing 9% Gain on Strong Analyst Backing and Impressive Financial Results

Stock News
·
Jul 02

SIMCERE PHARMA Shares Surge Nearly 8% in Afternoon Trading Following Research Collaboration Agreement with Stanford Medicine

Deep News
·
Jun 29

Simcere Pharmaceutical Group (SEHK:2096) Stock Could Be 70% Below Fair Value After Stanford IPF Deal

Simply Wall St.
·
Jun 21

Simcere Pharma Gets China Nod for Tumor Drug Trial

MT Newswires Live
·
Jun 15

Simcere Pharmaceutical Group Limited (HKG:2096) Passed Our Checks, And It's About To Pay A CN¥0.18 Dividend

Simply Wall St.
·
Jun 13

TransThera Sciences names Sun Delong chief operating officer

Reuters
·
Jun 12

SIMCERE PHARMA to Distribute Final Dividend of RMB 0.18 per Share on July 13

Stock News
·
Jun 12

SIMCERE PHARMA Receives NMPA Approval for Clinical Trial of SIM0689, a Dual-Target Antibody

Stock News
·
Jun 12

BRIEF-Simcere Pharmaceutical Receives Clinical Trial Approval For SIM0689 From China's NMPA

Reuters
·
Jun 12

Simcere Pharmaceutical - Receives Clinical Trial Approval for Sim0689 From National Medical Products Administration

THOMSON REUTERS
·
Jun 12

Simcere Pharmaceutical declares final dividend of RMB 0.18 per share for FY2025

Reuters
·
Jun 12

Simcere Pharmaceutical shareholders approve new articles of association, bylaw amendments

Reuters
·
Jun 12

Simcere Pharmaceutical partners with Stanford Medicine on idiopathic pulmonary fibrosis therapy research

Reuters
·
Jun 12

Simcere Pharmaceutical Enters Into a Research Collaboration Agreement With Stanford Medicine to Develop Innovative Therapies for Patients With Idiopathic Pulmonary Fibrosis

THOMSON REUTERS
·
Jun 12

SIMCERE PHARMA Shares Surge Over 3% Following Exclusive Distribution Deal for Novel Topical Treatment

Stock News
·
Jun 10